证券日报网讯 2月24日，长龄液压在互动平台回答投资者提问时表示，截至2026年2月13日收盘，公司 股东人数为8123户。 （文章来源：证券日报） ...

证券代码：605389 证券简称：长龄液压 公告编号：2026-009 江苏长龄液压股份有限公司 关于无锡核芯破浪科技合伙企业（有限合伙）要约收购公司股份 的第二次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本公告为无锡核芯破浪科技合伙企业（有限合伙）（以下简称"收购人" 或"核芯破浪"）要约收购江苏长龄液压股份有限公司（以下简称"公司"、"上 市公司"或"长龄液压"）股份的第一次提示性公告。 要约收购期限：本次要约收购期限共计 33 个自然日，即 2026 年 2 月 5 日至 2026 年 3 月 9 日。本次要约收购期限内最后三个交易日，预受的要约不可 撤回。 投资者接受要约可能导致经济损失：投资者若在要约期限内申报预受要 约且未在要约期限届满三个交易日前撤回（投资者在当日申报预受要约并在当日 申报时间结束前撤单的除外），则其接受要约的该部分公司股票将以 35.82 元/ 股的要约收购价格卖出给收购方核芯破浪。若届时公司股票价格高于本次要约收 购价格，则投资者将因接受要约而遭受损失。截至 ...

长龄液压公告称，无锡核芯破浪科技合伙企业向除其及其一致行动人以外的全体股东发出部分要约，预 定收购1729.04万股，占总股本12%，要约价35.82元/股，要约期2026年2月5日起33个自然日，最后3日 预受要约不可撤回。截至2月24日，公司股价72.88元/股，高于要约价。收购需最高资金6.19亿元，收购 人已存1.26亿元履约保证金。 ...

Group 1 - The core event for Changling Hydraulic (605389) is the partial tender offer initiated by Wuxi Core Wave Technology Partnership (Limited Partnership) [1] - The tender offer aims to acquire 17.29 million shares, representing 12.00% of the total share capital, at a price of 35.82 yuan per share, with the offer period from February 5 to March 9, 2026 [1] - The purpose of the tender offer is to increase the acquirer's shareholding ratio, enhance equity stability, and gain control of the company [1] Group 2 - Following the tender offer, Changling Hydraulic's stock price has shown a downward trend, closing at 72.80 yuan on February 13, 2026, with a daily decline of 0.26% and a cumulative drop of 4.96% over the past five days [2] - On February 13, the net outflow of main funds was 5.4535 million yuan, accounting for 7.95% of the total transaction volume, indicating short-term capital withdrawal pressure [2] - The number of shareholders increased to 8,058 as of February 10, reflecting a 4.53% rise, suggesting signs of market chip dispersion [2]

Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

江苏长龄液压股份有限公司 关于无锡核芯破浪科技合伙企业（有限合伙）要约收购公司股份 的第一次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本公告为无锡核芯破浪科技合伙企业（有限合伙）（以下简称"收购人" 或"核芯破浪"）要约收购江苏长龄液压股份有限公司（以下简称"公司"、"上 市公司"或"长龄液压"）股份的第一次提示性公告。 要约收购期限：本次要约收购期限共计 33 个自然日，即 2026 年 2 月 5 日至 2026 年 3 月 9 日。本次要约收购期限内最后三个交易日，预受的要约不可 撤回。 投资者接受要约可能导致经济损失：投资者若在要约期限内申报预受要 约且未在要约期限届满三个交易日前撤回（投资者在当日申报预受要约并在当日 申报时间结束前撤单的除外），则其接受要约的该部分公司股票将以 35.82 元/ 股的要约收购价格卖出给收购方核芯破浪。若届时公司股票价格高于本次要约收 购价格，则投资者将因接受要约而遭受损失。截至 2026 年 2 月 12 日，长龄液压 股票收盘价为 72.99 元/ ...

国联民生证券承销保荐有限公司 关于 无锡核芯破浪科技合伙企业（有限合伙） 要约收购 江苏长龄液压股份有限公司 之 独立财务顾问报告 独立财务顾问 签署日期：二〇二六年二月 国联民生证券承销保荐有限公司 江苏长龄液压股份有限公司之独立财务顾问报告 独立财务顾问声明和承诺 本部分所述的词语或简称与本独立财务顾问报告书"释义"部分所定义的词 语或简称具有相同的涵义。 2025 年 7 月 10 日，核芯听涛与夏继发、夏泽民，澄联双盈与夏继发分别签 署的《股份转让协议》，核芯听涛、澄联双盈拟协议收购夏继发、夏泽民持有的 长龄液压 43,211,714 股股份，占长龄液压股份总数的 29.99%。截至本独立财务 顾问报告签署日，前述协议转让股份已办理完成过户登记，收购人及其一致行动 人已持有长龄液压 29.99%股份。 本次要约收购为核芯破浪向除收购人及其一致行动人以外的长龄液压全体 股东发出的部分要约，预定要约收购股份数量为 17,290,448 股股份（占上市公司 股份比例为 12.00%），要约收购价格为 35.82 元/股。 本次要约收购以核芯听涛、澄联双盈协议收购夏继发、夏泽民持有的长龄液 压 43,211, ...

证券代码：605389 证券简称：长龄液压 江苏长龄液压股份有限公司董事会 关于 无锡核芯破浪科技合伙企业（有限合伙） 要约收购事宜 致全体股东的报告书 上市公司名称：江苏长龄液压股份有限公司 上市公司住所：江苏省无锡市江阴市云亭街道云顾路 885 号 上市地点：上海证券交易所 股票简称：长龄液压 股票代码：605389 董事会报告书签署日期：二〇二六年二月 0 有关各方及联系方式 上市公司名称：江苏长龄液压股份有限公司 上市公司住所：江苏省无锡市江阴市云亭街道云顾路 885 号 联系人：戴正平 联系电话：0510-80287803 收购人名称：无锡核芯破浪科技合伙企业（有限合伙） 收购人住所：江阴市中南路 1 号 A1 办公楼 308 室 收购人一致行动人名称：无锡核芯听涛科技合伙企业（普通合伙） 收购人一致行动人住所：江阴市中南路 1 号 A1 办公楼 304 室 收购人一致行动人名称：江阴澄联双盈投资合伙企业（有限合伙） 收购人一致行动人住所：江阴市创富 1 号 10 幢 1802 室 独立财务顾问名称：国联民生证券承销保荐有限公司 独立财务顾问住所：中国（上海）自由贸易区浦明路 8 号 联系人：叶云华 ...

江苏长龄液压股份有限公司 第三届董事会第八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 证券代码：605389 证券简称：长龄液压 公告编号：2026-008 （一）审议通过《关于<江苏长龄液压股份有限公司董事会关于无锡核芯破 浪科技合伙企业（有限合伙）要约收购事宜致全体股东的报告书>的议案》； 江苏长龄液压股份有限公司（以下简称"公司"）于 2026 年 2 月 12 日在本公 司会议室以现场表决方式召开第三届董事会第八次会议，会议通知于 2026 年 2 月 2 日通过书面及电子邮件等方式发出。会议应参会董事 5 名，实际参会董事 5 名，公司高级管理人员列席了会议，会议由董事长夏泽民先生主持，会议的召开 符合《中华人民共和国公司法》等有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、董事会会议审议情况 本次会议经全体参会董事审议并以记名方式投票表决通过了以下议案： 公司董事会根据《上市公司收购管理办法》《公开发行证券的公司信息披露 内容与格式准则第 18 号— ...

证券日报网讯 2月11日，长龄液压在互动平台回答投资者提问时表示，截至2026年2月10日收盘，长龄 液压股东人数为8058户。 （文章来源：证券日报） 证券日报网讯 2月11日，长龄液压在互动平台回答投资者提问时表示，截至2026年2月10日收盘，长龄 液压股东人数为8058户。 （文章来源：证券日报） ...